RVMD Revolution Medicines edges higher after reporting wider than expected Q4 2025 per share loss UONEK Urban One slips 042 after Q4 2025 earnings release with no consensus analyst estimate benchmarks New NFE Stock Valuation Gap Analysis Q4 2025 Profit Surprises